GlyProVac
OverviewSuggest Edit
GlyProVac is a company pursuing the development of glycoprotein based vaccines. It provides bacterial vaccine candidates based on its proprietary platform technology BEMAP, allowing identification of various types of O-linked protein glycosylation.
| Type | Private | |
| Founded | 2018 | |
| HQ | Odense, DK | Map |
| Website | glyprovac.com |
Locations
Latest Updates
| Employees (est.) (Nov 2021) | 6 | |
| Cybersecurity rating | A | More |
Key People/Management at GlyProVac
Ann Zahle Andersen
CBDO and Co-Founder
Anders Boysen
CEO, Co-founder and Co-inventor
Kirsten Winther
Chairman of the Board
GlyProVac Financials and Metrics
Summary Metrics
Founding Date | 2018 |
GlyProVac Cybersecurity Score
GlyProVac Online and Social Media Presence
GlyProVac's Trends
GlyProVac Frequently Asked Questions
When was GlyProVac founded?
GlyProVac was founded in 2018.
Who are GlyProVac key executives?
GlyProVac's key executives are Ann Zahle Andersen, Anders Boysen and Kirsten Winther.
How many employees does GlyProVac have?
GlyProVac has 6 employees.
Who are GlyProVac competitors?
Competitors of GlyProVac include Umoja Biopharma, Aprogen and Prosetta.
Where is GlyProVac headquarters?
GlyProVac headquarters is located at Rørhatten 4, Odense.
Where are GlyProVac offices?
GlyProVac has an office in Odense.
How many offices does GlyProVac have?
GlyProVac has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies